A Self‐Adjuvanting Large Pore 2D Covalent Organic Framework as a Vaccine Platform
Authors:
- Yalini H. WijesundaraYWYalini H. Wijesundara
- Niyati AroraNANiyati Arora
- Ryanne N. EhrmanRERyanne N. Ehrman
- Thomas Sinclair HowlettTHThomas Sinclair Howlett
- Ikeda TrashiITIkeda Trashi
- Orikeda TrashiOTOrikeda Trashi
- Sneha KumariSKSneha Kumari
- Wendy TangWTWendy Tang
- Katarzyna H. DrewniakKDKatarzyna H. Drewniak
- 16 December 2024
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 64 (5) , e202413020
Abstract
Vaccines are one of the greatest human achievements in public health, as they help prevent the spread of diseases, reduce illness and death rates, saving thousands of lives with few side effects. Traditional vaccine development is centered around using live attenuated or inactivated pathogens, which is expensive and has resulted in vaccine‐associated illnesses. Advancements have led to the development of safer subunit vaccines, which contain recombinant proteins isolated from pathogens. Their short half‐life and small size make most subunit vaccines less immunogenic. Here, we introduce a large pore 2D covalent organic framework (COF), PyCOFamide, as a promising solution for an effective subunit platform. Our study demonstrates that simple adsorption of a model antigen, ovalbumin (OVA), onto PyCOFamide (OVA@COF) significantly enhances humoral and cell‐mediated immune response compared to free OVA. OVA@COF exhibited heightened immune cell activation and acts as an antigen reservoir, facilitating antigen‐presenting cell trafficking to the draining lymph nodes, amplifying the humoral immune response. Additionally, the breakdown of the COF releases monomers that adjuvant the activation of immune cells vital to creating strong immunity. This platform offers a potential avenue for safer, more effective subunit vaccines.Keywords
Funding Information
- Welch Foundation (AT-1989-20190330, X-AT-0004-20230731)
This publication has 72 references indexed in Scilit:
- Vaccines and sera2023
- Recent Progress in Nanoscale Covalent Organic Frameworks for Cancer Diagnosis and TherapyNano-Micro Letters, 2021
- Biomaterials and nanomaterials for sustained release vaccine deliveryWIREs Nanomedicine and Nanobiotechnology, 2021
- Controlling timing and location in vaccinesAdvanced Drug Delivery Reviews, 2020
- Life-Threatening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of ImmunityJournal of Clinical Immunology, 2019
- Development of subcutaneous allergen immunotherapy (part 2): preventive aspects and innovationsAllergo Journal International, 2019
- Opportunities of Covalent Organic Frameworks for Advanced ApplicationsAdvanced Science, 2018
- Modern Subunit Vaccines: Development, Components, and Research OpportunitiesChemMedChem, 2013
- Preclinical Toxicology of Vaccines2013
- Drug delivery from structured porous inorganic materialsWIREs Nanomedicine and Nanobiotechnology, 2011